50
Participants
Start Date
October 31, 2003
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Allogenic islet cells (human, U. Chicago)
Human allogenic islet cells. Immunosuppression varies but may include prograf, celcept, sirolimus, prednisone. Dosage will vary per patient based on weight. Patients will receive immunosuppression medications while islet cells are functioning.
Intraportal infusion of islet cells
Intraportal infusion of islet cell through the portal vein in the liver.
The University of Chicago Hospitals, Chicago
University of Chicago
OTHER